Spark Biomedical Secures Health Canada License for Sparrow Ascent: A Breakthrough Solution for Opioid Withdrawal

Dallas, TX, March 5, 2025 – Spark Biomedical has exciting news! They’ve just received a Medical Device License from Health Canada for their Sparrow Ascent™ device. This innovative device is designed to help those going through opioid withdrawal without using drugs. With this approval, Spark Biomedical can now offer Sparrow Ascent to people and healthcare providers all over Canada. It presents a safe and comfortable option for those dealing with opioid use disorder. Safe Science Solutions will be the exclusive distributor in Canada.

Daniel Powell, the CEO of Spark Biomedical, shared his enthusiasm: “Getting Health Canada’s Medical Device License is a big step for us. Now we can provide a drug-free solution for those struggling with opioid withdrawal. We want to offer hope and a clear path for people battling opioid dependence. Our partnership with Safe Science Solutions will help us reach those who need this treatment the most.”

So, what is Spark Biomedical all about? They are a leading medical device developer based in the U.S. Their focus is on creating wearables that use neurostimulation for various health needs, from behavioral health to chronic pain. They’re committed to advancing bioelectronic medicine, working with federal agencies like the NIH and DoD, and collaborating with schools and private institutions. Spark Biomedical aims to change the future of patient care by providing innovative and effective treatment options.

For more details, you can reach out to Udim Obot at udim.obot@sparkbiomedical.com.